All Infection Prevention & Control articles – Page 3
-
NewsUltrasound-activated ‘nanoagents’ kill superbugs hiding in biofilms
Scientists have designed nanoagents that act like smart drug‑delivery capsules – carrying an antibiotic deep into bacterial infection sites and releasing it only when activated by gentle ultrasound.
-
NewsScientists identify therapeutic target that would curb the spread of coronaviruses
Coronaviruses not only use the machinery of the human cells they infect: they modify it to achieve optimal conditions to produce viral proteins and thus spread more quickly, according to a study identifying enzymes that modify transfer RNAs as key elements for coronavirus infection.
-
NewsCell-free DNA offers early warning for bloodstream infections in kids with leukemia
Researchers show that microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before the symptoms appear. Plasma microbial cell-free DNA sequencing (mcfDNA-Seq) offer a potential approach to protecting vulnerable patients by allowing treatment to start before the patient gets sick.
-
NewsNew study demonstrates universal newborn cCMV screening leads to earlier detection and increased identification of mild hearing loss
A new retrospective cohort study examining the impact of Minnesota’s first-in-the-nation mandated universal newborn screening for congenital cytomegalovirus (cCMV) shows that universal screening significantly decreased the age at first audiology visit and increased identification of mild hearing loss in infants.
-
NewsBiomarkers indicating higher liver cancer risk in chronic hepatitis B patients identified
Researchers have identified Hepatitis B RNA serum levels as a biomarker that more accurately stratifies risk of liver cancer in individuals who have been functionally cured of chronic hepatitis B.
-
NewsStudy reveals immune blueprint for next-generation malaria vaccine
New research has uncovered how the human immune system fights Plasmodium vivax, paving the way for the first effective vaccine against the most widespread form of malaria. It provides critical evidence of how protective immunity to P. vivax works, identifying specific targets on the parasite.
-
NewsTackling tuberculosis systematically: How the environment shapes TB risk
Researchers introduce the concept of the “tuberculogenic environment”: the complex interplay of structures, rules, and living conditions that keep certain communities at high TB risk, even when care is available.
-
NewsBacterial cellulose as a sustainable vehicle for the controlled release of nisin and mandelic acid: A clean beauty-based approach for acne treatment
A new study developed a bacterial cellulose-based delivery system loaded with nisin and mandelic acid, targeting acne treatment. Bacterial cellulose, derived from Komagataebacter xylinus, served as a biocompatible, biodegradable matrix to control the release of bioactive compounds.
-
NewsA highly precise target for medications against tropical diseases
Researchers have discovered a critical vulnerability shared by the pathogens that cause African sleeping sickness, Chagas disease and leishmaniasis. The PEX38 protein plays a crucial role in the formation of certain organelles of the trypanosomes that are essential for their energy supply.
-
NewsFe₃O₄@mPEG-Ag nanoparticles: a new frontier in combating antibiotic resistance
A collaborative study introduces Fe₃O₄@mPEG-Ag nanoparticles (NPs) as a groundbreaking non-antibiotic strategy to combat drug-resistant bacteria, offering the antibacterial properties of silver (Ag) with the stability and biocompatibility of magnetite (Fe₃O₄) modified by methoxy poly(ethylene glycol) (mPEG).
-
NewsImaging technique is step towards needed treatments for hantaviruses in new molecular ma
Researchers have produced a detailed blueprint, the highest resolution yet, for a protein complex the Andes virus uses to infect host cells. The new detailed structural information enabled the researchers to produce a vaccine candidate that caused mice to produce neutralizing antibodies against the Andes virus.
-
NewsAcoziborole Winthrop receives European Medicines Agency positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness
The European Medicines Agency has granted a positive opinion to Acoziborole Winthrop (acoziborole) as a single-dose oral treatment for both early- and advanced-stage gambiense sleeping sickness in adults as well as in adolescents 12 years and older weighing at least 40 kilograms.
-
NewsScientists identify key protein that stops malaria parasite growth
An international team of scientists have identified a unique protein essential for the malaria parasite’s survival and transmission. Aurora-related kinase 1 (ARK1) acts as a ‘traffic controller’ during the parasite’s unusual cell division and growth process.
-
NewsDiffering immune responses in infants may explain increased severity of RSV over SARS-CoV-2
Reseachers report that the two respiratory viruses trigger different immune responses. Those differences might explain why these two diseases have different clinical outcomes and require different treatment strategies.
-
NewsEmerging class of antibiotics to tackle global tuberculosis crisis
Researchers investigated how three naturally occurring antibiotic compounds – ecumicin, ilamycin and cyclomarin – act on a vital protein degradation machine inside Mycobacterium tuberculosis, the bacterium that causes TB.
-
NewsHPV vaccination provides “sustained protection” against cervical cancer
Human papillomavirus (HPV) vaccination is associated with a significantly reduced risk of invasive cervical cancer, with no indication of waning protection up to 18 years after vaccination, finds a study.
-
NewsVaccine uptake: Why conspiracy theories can be so irresistible
New research has found that understanding how someone processes information can be a strong predictor of whether they are drawn to conspiracy beliefs that can influence vaccine uptake, trust in institutions and responses to emergencies.
-
NewsMeningococcal B vaccination does not reduce gonorrhoea, trial results show
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhoea, according to the results of the world’s largest randomised control trial (RCT) into possible efficacy.
-
NewsUrinary tract infections can trigger delirium and worsen dementia
Urinary tract infections can pose serious risks for older adults, particularly those with Alzheimer’s disease and other forms of dementia. In older patients, a common UTI can trigger delirium, a medical emergency marked by sudden confusion and altered awareness.
-
NewsNew strategies aim at HIV’s last strongholds
A new study has overcome a long-standing challenge—how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure.